Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001692373 | SCV001910672 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002070223 | SCV002351138 | likely benign | Fanconi anemia | 2024-10-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002476624 | SCV002795361 | likely benign | Fanconi anemia complementation group C | 2021-07-11 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001354456 | SCV001549075 | uncertain significance | Malignant tumor of breast | no assertion criteria provided | clinical testing | The FANCC c.1533+13G>A variant was not identified in the literature nor was it identified in the ClinVar or LOVD 3.0 databases. The variant was identified in dbSNP (ID: rs200515307) as well as in control databases in 7 of 276694 chromosomes at a frequency of 0.00003 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 1 of 24028 chromosomes (freq: 0.00004), European in 6 of 126238 chromosomes (freq: 0.00005), while the variant was not observed in the Other, Latino, Ashkenazi Jewish, East Asian, Finnish, or South Asian populations. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |